A Centre of Excellence for Lead Optimisation for Diseases of the Developing World (Joint funding by Wellcome & Gates)

StatusFinished
Effective start/end date1/07/13 → 31/10/18

Funding

  • Wellcome Trust (100195/Z/12/Z (VIA MILESTONE)): £3,572,417.00
View all
View less

Related content

Research Outputs

A role for trypanosomatid aldo-keto reductases in methylglyoxal, prostaglandin and isoprostane metabolism

Research output: Contribution to journal › Article